Haemonetics Corporation Completes Acquisition of OpSens Inc.

Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, has completed its previously announced acquisition of OpSens Inc., a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology. Haemonetics acquired all outstanding shares of OpSens for CAD $2.90 per share in the all-cash transaction, representing a fully diluted equity value of approximately USD $255 million at the current exchange rate. In connection with the closing of the transaction, OpSens’ common shares will cease trading in the public market and will be delisted from the Toronto Stock Exchange and withdrawn from the OTCQX.

Read the full article: Haemonetics Corporation Completes Acquisition of OpSens Inc. //

Source: https://www.prnewswire.com/news-releases/haemonetics-corporation-completes-acquisition-of-opsens-inc-302012273.html

Leave a Comment

Your email address will not be published.

Scroll to Top